Clinical Trial Details

Trial ID: L0704
Source ID: NCT04364360
Associated Drug: Sulforaphane
Title: Fatty Acid MetabOlism in Individuals Undergoing Sulforaphane Supplementation (FAMOUS)
Acronym: FAMOUS
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: Non-Alcoholic Fatty Liver Disease;Obesity;Metabolic Syndrome
Interventions: Dietary Supplement: Sulforaphane extract
Outcome Measures: Change in whole-body fatty acid oxidationChange in liver fat content;Change in hepatic fatty acid partitioning;Change in glycemic control
Sponsor/Collaborators: University of Oxford
Gender: All
Age: 18 Years65 Years
Phases: Not applicable
Enrollment: 60
Study Type: Interventional
Study Designs: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Start Date: 06/04/2020
Completion Date: --
Results First Posted: --
Last Update Posted: 10 May 2021
Locations: United Kingdom
URL: https://clinicaltrials.gov/show/NCT04364360